ResMed Price to Book Ratio 2010-2024 | RMD
Historical price to book ratio values for ResMed (RMD) over the last 10 years. The current price to book ratio for ResMed as of November 22, 2024 is 6.89.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ResMed Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-21 | 243.60 | 6.88 | |
| 2024-09-30 | 243.60 | $35.39 | 6.88 |
| 2024-06-30 | 190.57 | $33.11 | 5.76 |
| 2024-03-31 | 196.71 | $31.52 | 6.24 |
| 2023-12-31 | 170.43 | $30.47 | 5.59 |
| 2023-09-30 | 146.03 | $28.90 | 5.05 |
| 2023-06-30 | 215.19 | $28.08 | 7.66 |
| 2023-03-31 | 215.27 | $26.77 | 8.04 |
| 2022-12-31 | 204.19 | $25.45 | 8.02 |
| 2022-09-30 | 213.72 | $23.44 | 9.12 |
| 2022-06-30 | 204.85 | $22.95 | 8.92 |
| 2022-03-31 | 236.46 | $22.42 | 10.55 |
| 2021-12-31 | 253.55 | $21.52 | 11.78 |
| 2021-09-30 | 256.13 | $20.77 | 12.33 |
| 2021-06-30 | 239.22 | $19.81 | 12.07 |
| 2021-03-31 | 187.89 | $18.62 | 10.09 |
| 2020-12-31 | 205.45 | $19.69 | 10.43 |
| 2020-09-30 | 165.39 | $18.49 | 8.95 |
| 2020-06-30 | 184.84 | $17.23 | 10.73 |
| 2020-03-31 | 141.46 | $15.60 | 9.07 |
| 2019-12-31 | 148.50 | $15.62 | 9.51 |
| 2019-09-30 | 129.12 | $14.73 | 8.77 |
| 2019-06-30 | 116.62 | $14.42 | 8.08 |
| 2019-03-31 | 99.36 | $14.10 | 7.05 |
| 2018-12-31 | 108.40 | $13.65 | 7.94 |
| 2018-09-30 | 109.43 | $13.34 | 8.21 |
| 2018-06-30 | 97.93 | $14.43 | 6.79 |
| 2018-03-31 | 92.77 | $14.48 | 6.41 |
| 2017-12-31 | 79.49 | $14.13 | 5.62 |
| 2017-09-30 | 71.92 | $14.41 | 4.99 |
| 2017-06-30 | 72.43 | $13.79 | 5.25 |
| 2017-03-31 | 66.61 | $13.08 | 5.09 |
| 2016-12-31 | 57.16 | $12.08 | 4.73 |
| 2016-09-30 | 59.34 | $12.58 | 4.72 |
| 2016-06-30 | 57.64 | $12.05 | 4.78 |
| 2016-03-31 | 52.43 | $11.92 | 4.40 |
| 2015-12-31 | 48.43 | $10.89 | 4.45 |
| 2015-09-30 | 45.73 | $10.47 | 4.37 |
| 2015-06-30 | 50.31 | $11.30 | 4.45 |
| 2015-03-31 | 63.75 | $10.91 | 5.84 |
| 2014-12-31 | 49.57 | $11.32 | 4.38 |
| 2014-09-30 | 43.33 | $11.83 | 3.66 |
| 2014-06-30 | 44.29 | $12.53 | 3.53 |
| 2014-03-31 | 38.90 | $12.05 | 3.23 |
| 2013-12-31 | 40.76 | $11.58 | 3.52 |
| 2013-09-30 | 45.51 | $11.92 | 3.82 |
| 2013-06-30 | 38.69 | $11.34 | 3.41 |
| 2013-03-31 | 39.61 | $12.39 | 3.20 |
| 2012-12-31 | 35.37 | $12.22 | 2.90 |
| 2012-09-30 | 34.29 | $11.88 | 2.89 |
| 2012-06-30 | 26.32 | $11.32 | 2.33 |
| 2012-03-31 | 26.07 | $11.23 | 2.32 |
| 2011-12-31 | 21.43 | $10.79 | 1.99 |
| 2011-09-30 | 24.29 | $10.48 | 2.32 |
| 2011-06-30 | 26.11 | $11.41 | 2.29 |
| 2011-03-31 | 25.31 | $10.90 | 2.32 |
| 2010-12-31 | 29.22 | $10.50 | 2.78 |
| 2010-09-30 | 27.68 | $9.73 | 2.84 |
| 2010-06-30 | 25.65 | $8.51 | 3.01 |
| 2010-03-31 | 26.85 | $8.79 | 3.05 |
| 2009-12-31 | 22.05 | $8.36 | 2.64 |
| 2009-06-30 | 17.18 | $7.41 | 2.32 |
| 2009-03-31 | 14.91 | $6.45 | 2.31 |
| 2009-09-30 | 19.06 | $8.02 | 2.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.786B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.249B | 26.05 |
| Stryker (SYK) | United States | $146.711B | 33.06 |
| Boston Scientific (BSX) | United States | $132.644B | 38.14 |
| EssilorLuxottica (ESLOY) | France | $112.106B | 0.00 |
| Medtronic (MDT) | Ireland | $110.562B | 16.42 |
| Haleon (HLN) | United Kingdom | $43.682B | 28.38 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.166B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.665B | 19.54 |
| Terumo (TRUMY) | Japan | $29.739B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.805B | 18.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.942B | 13.97 |
| Insulet (PODD) | United States | $18.443B | 73.44 |
| Baxter (BAX) | United States | $16.957B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.158B | 40.72 |
| Bio-Rad Laboratories (BIO) | United States | $9.320B | 31.68 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.294B | 14.62 |
| TG Therapeutics (TGTX) | United States | $5.459B | 0.00 |
| Haemonetics (HAE) | United States | $4.297B | 20.97 |
| Prestige Consumer Healthcare (PBH) | United States | $4.192B | 20.85 |
| ICU Medical (ICUI) | United States | $4.125B | 39.27 |
| Perrigo (PRGO) | Ireland | $3.830B | 11.27 |
| Envista Holdings (NVST) | United States | $3.697B | 27.54 |
| Neogen (NEOG) | United States | $3.246B | 37.45 |
| Agios Pharmaceuticals (AGIO) | United States | $3.175B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.841B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.700B | 17.38 |
| LeMaitre Vascular (LMAT) | United States | $2.428B | 59.00 |
| Warby Parker (WRBY) | United States | $2.349B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.913B | 33.48 |
| AtriCure (ATRC) | United States | $1.742B | 0.00 |
| InMode (INMD) | Israel | $1.597B | 9.61 |
| AdaptHealth (AHCO) | United States | $1.326B | 9.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.318B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.267B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.207B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.952B | 7.44 |
| CeriBell (CBLL) | United States | $0.943B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.918B | 30.68 |
| Capricor Therapeutics (CAPR) | United States | $0.847B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.684B | 30.25 |
| Omeros (OMER) | United States | $0.632B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.533B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.468B | 0.00 |
| Quanterix (QTRX) | United States | $0.451B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.95 |
| Valneva SE (VALN) | France | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.341B | 32.41 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Biote (BTMD) | United States | $0.325B | 7.12 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Zynex (ZYXI) | United States | $0.263B | 55.07 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.29 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| MacroGenics (MGNX) | United States | $0.203B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.167B | 100.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| Jin Medical (ZJYL) | China | $0.164B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.67 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.74 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Ayr Wellness (AYRWF) | United States | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| Modular Medical (MODD) | United States | $0.058B | 0.00 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Safety Shot (SHOT) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |